John P. Pribble

3.8k citations

37 papers · 2.3k indexed · 1 hit paper · h-index 19

Impact in

Critical Care and Intensive Care Medicine top 2%
- Intensive Care Unit Cognitive Disorders
Immunology top 2%
- Immune Response and Inflammation
- Inflammation biomarkers and pathways

Papers in

Immunology 17
- Immune Response and Inflammation 16
- Immune Cell Function and Interaction 2
Critical Care and Intensive Care Medicine 3

Co-authors: Steven M. Opal Michael A. Catalano Lyle L. Moldawer Tim Axtelle John E. Palardy Duane C. Bloedow Mark White Jean‐Louis Vincent
Journals: Critical Care Medicine (9 papers)The Journal of Infectious Diseases (3 papers)Gastrointestinal Endoscopy (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)The Journal of Immunology (2 papers)
Partner nations: United States Germany Netherlands

In The Last Decade

John P. Pribble

37 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock 1999 · 505 citations

Peers

Countries citing papers authored by John P. Pribble

Since Specialization

Citations

This map shows the geographic impact of John P. Pribble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Pribble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Pribble more than expected).

Fields of papers citing papers by John P. Pribble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Pribble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Pribble. The network helps show where John P. Pribble may publish in the future.

Co-authors

The 25 scholars most cited alongside John P. Pribble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John P. Pribble Line = papers co-authored together John P. Pribble links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Results from a First-in-Human Trial of a Novel Vascular Sealant Frontiers in Surgery ·Hans-Joachim Florek, Jan Brunkwall, Karl‐Heinz Orend, Ian M. Handley, John P. Pribble, Robert L. Simison	2015	16
2	Immunogenicity and Safety of Re-Exposure to Recombinant Human Thrombin in Surgical Hemostasis Journal of the American College of Surgeons ·Neil Singla, Antonios Gasparis, Jeffrey L. Ballard, Brenden Hedblom, Michael D. Butine, John P. Pribble, Arkadi Menezes Popoff	2011	10
3	Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: A potential clinical marker and mediator of severe sepsis* Critical Care Medicine ·Steven M. Opal, Yow‐Pin Lim, Patricia K. Jeys, Lyle L. Moldawer, John P. Pribble, John E. Palardy, Sonia Souza	2007	39
4	Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial* Critical Care Medicine ·Steven M. Opal, Pierre‐François Laterre, Edward Abraham, Bruno François, Xavier Wittebole, S. C. Lowry, Jean-François Dhainaut, Brian Warren, Thierry Dugernier, Ángel Crespo López, Miguel Sánchez, Ignace Demeyer, Luis Jáuregui, José A. Lorente, William T. McGee, Konrad Reinhart, Safa’a Mohammad Khalil, Sonia Souza, John P. Pribble	2004	103
5	CD14 receptor occupancy in severe sepsis: Results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)* Critical Care Medicine ·Konrad Reinhart, Thomas Glück, Jack J. M. Ligtenberg, Klaus Tschaikowsky, Barbara Gawłowska, Jan Bakker, Steven M. Opal, Lyle L. Moldawer, Tim Axtelle, Terence Turner, Sonia Souza, John P. Pribble	2004	57
6	Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial* Critical Care Medicine ·Daniel P. Schuster, Michael H. Metzler, Steven M. Opal, S. C. Lowry, R.A. Balk, Edward Abraham, Howard Levy, Gus J. Slotman, Nieve Dee, Sonia Souza, John P. Pribble	2003	62
7	An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody Journal of Endotoxin Research ·Tim Axtelle, John P. Pribble	2003	13
8	An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody Journal of Endotoxin Research ·Tim Axtelle, John P. Pribble	2003	15
9	Effects of IC14, an Anti‐CD14 Antibody, on Coagulation and Fibrinolysis during Low‐Grade Endotoxemia in Humans The Journal of Infectious Diseases ·Annelies Verbon, Joost C.M. Meijers, C. Arnold Spek, C. Erik Hack, John P. Pribble, Terence Turner, Pascale E. P. Dekkers, Tim Axtelle, Marcel Levi, Sander J. H. van Deventer, Pieter H. Reitsma, Tom van der Poll	2002	35
10	Phase 1 study with recombinant chimeric monoclonal antibody against human CD14 (IC14) in patients with severe sepsis Critical Care Medicine ·Konrad Reinhart, Renata Pereira Bender Monteiro, Jack J. M. Ligtenberg, Klaus Tschaikowsky, Barbara Gawłowska, Joost M. Bakker, Steven M. Opal, Terence Turner, Горнаева Марина Дмитриевна, Tim Axtelle, John P. Pribble	2001	3
11	IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans The Journal of Immunology ·Annelies Verbon, Pascale E. P. Dekkers, Tessa ten Hove, C. Erik Hack, John P. Pribble, Terence Turner, Sonia Souza, Tim Axtelle, Frans J. Hoek, Sander J. H. van Deventer, Tom van der Poll	2001	102
12	AN EVALUATION OF RECOMBINANT HUMAN PLATELET ACTIVATING FACTOR ACETYLHYDROLASE (rPAF-AH) IN PATIENTS AT RISK FOR DEVELOPING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Critical Care Medicine ·Michael H. Metzler, R.A. Balk, Daniel P. Schuster, Gus J. Slotman, John Michael, Janice L. Zimmerman, Nieve Dee, John P. Pribble	1999	4
13	Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock The Journal of Infectious Diseases ·Steven M. Opal, Patrick J. Scannon, Jean‐Louis Vincent, Mark White, Stephen F. Carroll, John E. Palardy, Nicolas A. Parejo, John P. Pribble, Jon H. Lemke Hit paper breakdown →	1999	505
14	Use of Predicted Risk of Mortality to evaluate the efficacy of anticytokine therapy in sepsis Critical Care Medicine ·William A. Knaus, Frank E. Harrell, John F. LaBrecque, Douglas P. Wagner, John P. Pribble, Elizabeth A. Draper, Rosemary Sheffield, J. Evenaar	1996	78
15	In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate The American Journal of Emergency Medicine ·Sharon Watling, Ahmad Kafri, Charles W. Gehrke, Robert W. Zumwalt, John P. Pribble	1995	20
16	Influence of IL-1 receptor blockade on the human response to endotoxemia. The Journal of Immunology ·Kimberly J. Van Zee, S M Coyle, S E Calvano, Hester S. A. Oldenburg, David Stiles, John P. Pribble, Maria Graziella Catalano, Lyle L. Moldawer, S. F. Lowry	1995	56
17	Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial Critical Care Medicine ·Charles J. Fisher, Gus J. Slotman, Steven M. Opal, John P. Pribble, Roger C. Bone, George Emmanuel, David P. Ng, Duane C. Bloedow, Michael A. Catalano	1994	351
18	Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans Cytokine ·Eric V. Granowitz, Reuven Porat, James W. Mier, John P. Pribble, David Stiles, Duane C. Bloedow, Michael A. Catalano, Sheldon Wolff, Charles A. Dinarello	1992	182
19	Aerosolized Metaproterenol in the Treatment of Asthmatics with Severe Airflow Obstruction CHEST Journal ·Gary Salzman, Mark T. Steele, John P. Pribble, Robert M. Elenbaas, P. Oberhuemer	1989	44
20	Blood pressure effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock Annals of Emergency Medicine ·Robert L. Muelleman, John P. Pribble, Joseph A. Salomone	1988	7

About John P. Pribble

John P. Pribble is a scholar working on Immunology, Critical Care and Intensive Care Medicine, Hematology, Epidemiology and Immunology and Allergy, having authored 37 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (16 papers), Sepsis Diagnosis and Treatment (14 papers), Hemostasis and retained surgical items (5 papers), Pneumonia and Respiratory Infections (4 papers), Surgical Sutures and Adhesives (4 papers), Neonatal and Maternal Infections (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (243 citations), Immunology (957 citations), Epidemiology (956 citations), Microbiology (85 citations) and Hematology (139 citations). John P. Pribble has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Steven M. Opal, Michael A. Catalano, Lyle L. Moldawer, Tim Axtelle, John E. Palardy, Duane C. Bloedow, Mark White, Jean‐Louis Vincent, Patrick J. Scannon and Jon H. Lemke. Their work appears in journals such as Critical Care Medicine, The Journal of Infectious Diseases, Gastrointestinal Endoscopy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact